The global drug-eluting implants market is expected to reach US$8.483 billion by the end of 2026, increasing from US$6.050 billion in 2019, growing at a CAGR of 6.28% during the forecast period. The continuous increment in the number of diabetic patients overall is required to contribute significantly towards the market development of the drug-eluting implants market during the next few years.